机构:[1]West China School of Public Health and West China Fourth Hospital, and State Key Laboratory of Biotherapy, Sichuan University, Chengdu, PR China.[2]School of Pharmacy, Macau University of Science and Technology, Macau, SAR, PR China.[3]Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, PR China.[4]Xiangya School of Medicine, Central South University, Changsha, 410013, PR China.[5]State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Rui-Jin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, PR China.[6]Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, PR China.南方医科大学珠江医院[7]Center for Precision Medicine Research and Training, Faculty of Health Sciences, University of Macau, Macau, SAR, PR China.[8]University of the Chinese Academy of Sciences, Beijing, China.[9]State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, PR China.[10]Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA.[11]Translational Radiobiology, Department of Radiation Oncology, Universitatsklinikum Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Germany.[12]Department of Biomedical Informatics, School of Life Sciences, Central South University, Changsha, PR China.[13]Thoracic Surgery Branch, Center for Cancer Research, NCI, NIH, Bethesda, MD, 20892, USA.
Thiswork
was fundedby theNationalNaturalScience Foundation ofChina (GrantNos.
82060475, 81472594, 81770781, 82270825, 82303953), Chunhui program
of theChinese Ministry ofEducation (GrantNo.HZKY20220231), theNatural
Science Foundation of Guizhou Province (Grant No. ZK2022-YB632),
Guangdong Basic and Applied Basic Research Foundation (Grant No.
2021A1515011743), Youth Talent Project ofGuizhou ProvincialDepartment
of Education (Grant No. QJJ2022-224), China Postdoctoral Science Foundation
(Grant No. 2021M703733), China Lung Cancer Immunotherapy
Research Project, Special funds for innovation inHunan Province (GrantNo.
2020SK2062), Excellent Young Talent Cultivation Project of Zunyi City
(Zunshi Kehe HZ (2023) 142), Future Science and Technology Elite Talent
Cultivation Project of Zunyi Medical University (ZYSE-2023-02) and Collaborative
Innovation Center of Chinese Ministry of Education (Grant No.
2020-39).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|1 区生物学
小类|1 区生物学
最新[2023]版:
大类|1 区生物学
小类|1 区生物学
第一作者:
第一作者机构:[1]West China School of Public Health and West China Fourth Hospital, and State Key Laboratory of Biotherapy, Sichuan University, Chengdu, PR China.
通讯作者:
通讯机构:[3]Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, PR China.[9]State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, PR China.[11]Translational Radiobiology, Department of Radiation Oncology, Universitatsklinikum Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Germany.[12]Department of Biomedical Informatics, School of Life Sciences, Central South University, Changsha, PR China.
推荐引用方式(GB/T 7714):
Li Shensuo,Peng Yuzhong,Chen Minjun,et al.Facilitating integrative and personalized oncology omics analysis with UCSCXenaShiny[J].Communications Biology.2024,7(1):1200.doi:10.1038/s42003-024-06891-2.
APA:
Li Shensuo,Peng Yuzhong,Chen Minjun,Zhao Yankun,Xiong Yi...&Wang Shixiang.(2024).Facilitating integrative and personalized oncology omics analysis with UCSCXenaShiny.Communications Biology,7,(1)
MLA:
Li Shensuo,et al."Facilitating integrative and personalized oncology omics analysis with UCSCXenaShiny".Communications Biology 7..1(2024):1200